Insurers and drug-industry middlemen are cashing in on the weight-loss drug frenzy

Insurers and drug-industry middlemen are cashing in on the weight-loss drug frenzy

For US health insurers, explosive demand for new weight-loss drugs likely means bigger profits. The craze for drugs that help with weight loss, such as Ozempic and Wegovy, has shown no signs of abat… [+4167 chars]

Read More